Edwards Lifesciences advances after-hours after settling transcatheter patent litigation with Abbott Check out this evening's top movers from around Wall Street, compiled by The Fly.
HIGHER
- INMute Bio (INMB) up 91.5% after clinical data demonstrating that its lead drug candidate, XPro1595, decreases neuroinflammation in patients with Alzheimer's disease
- Vanda Pharma (VNDA) up 8.0% after being granted FDA authorization for Individual Patient Expanded Access Protocol
- Frequency Therapeutics (FREQ) up 3.5% after being initiated with Outperform at Oppenheimer
- Edwards Lifesciences (EW) up 2.0% after settling global transcatheter patent litigation
with Abbott
- Boeing (BA) up 1.3% after being awarded $22.9B US Air Force contract
LOWER
- Osmotica Pharma (OSMT) down 8.2% after equity offering
- Altimmune (ALT) down 3.8% after equity offering
Symbols:
INMB VNDA FREQ EW BA - $175.62 /
-2.825 (-1.58%)
OSMT ALT Keywords: fly intel, wall street, afterhours, movers, top stories, stocks